NasdaqGS:RXRXBiotechs
Is It Time To Reassess Recursion Pharmaceuticals (RXRX) After Recent Share Price Weakness
If you are wondering whether Recursion Pharmaceuticals' current share price gives you enough value for the risk you are taking, you are not alone.
The stock closed at US$4.67, with returns of 0.2% over the last 7 days, a 0.2% decline over 30 days, an 11.2% gain year to date, and a 28.5% decline over the past year, which can change how investors think about both potential and risk.
Recent attention on Recursion has focused on its position within the pharmaceuticals and biotech space and how...